+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Generalized Anxiety Disorder Market by Treatment Type, Distribution Channel, Patient Age Group, Gender, Symptom Severity - Global Forecast to 2030- Product Image
Generalized Anxiety Disorder Market by Treatment Type, Distribution Channel, Patient Age Group, Gender, Symptom Severity - Global Forecast to 2030- Product Image
Sale

Generalized Anxiety Disorder Market by Treatment Type, Distribution Channel, Patient Age Group, Gender, Symptom Severity - Global Forecast to 2030

  • PDF Icon

    Report

  • 187 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6016467
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior executives and market leaders navigating the evolving landscape of mental health care are seeking actionable insights to respond to surging demand and complex operational dynamics within the Generalized Anxiety Disorder market. This report delivers a concise strategic overview, highlighting transformational trends, core market divisions, and emerging opportunities.

Market Snapshot: Generalized Anxiety Disorder Market Outlook

The Generalized Anxiety Disorder Market grew from USD 2.23 billion in 2024 to USD 2.36 billion in 2025. It is expected to continue growing at a CAGR of 5.56%, reaching USD 3.09 billion by 2030. This trajectory reflects sustained investment, expanded treatment access, and heightened demand from a diverse patient population. Shaping this momentum are advancements in digital therapeutics, integration of telehealth services, and increased healthcare expenditure across established and emerging economies. Economic and regulatory factors are prompting companies to review cost structures while capitalizing on innovation. Strategic shift towards comprehensive care is enhancing the market environment for both established and new entrants.

Scope & Segmentation

  • Treatment Modalities: Digital therapeutics, prescription drugs, over-the-counter supplements, and therapy services.
  • Digital Solutions: Cognitive behavioral therapy apps, mindfulness apps, online mental health platforms, and virtual reality tools.
  • Pharmaceutical Categories: Benzodiazepines, buspirone, SNRIs, and SSRIs.
  • Therapeutic Approaches: Cognitive behavioral therapy, psychodynamic therapy, group therapy, and supportive counseling.
  • Distribution Channels: Hospital pharmacies, online and telepharmacy services, e-commerce portals, and retail pharmacy outlets.
  • Patient Demographics: Segmented by adolescents, adults, children, and elderly populations for tailored intervention strategies.
  • Gender and Severity: Solutions address different needs across female and male patients and target interventions according to mild, moderate, or severe symptoms.
  • Regions Covered: Americas, Europe/Middle East/Africa, Asia-Pacific, with a breakdown by key countries and economic zones.
  • Key Players: Companies analyzed include Pfizer Inc., Eli Lilly and Company, GlaxoSmithKline plc, AbbVie Inc., H. Lundbeck A/S, Roche Holding AG, Teva Pharmaceuticals Industries Ltd., Viatris Inc., Sandoz International GmbH, and Dr. Reddy’s Laboratories Ltd.

Key Takeaways

  • Digital health adoption and telemedicine offerings are broadening patient engagement, making care more widely accessible and reducing barriers across geographies.
  • Personalization of care is becoming a market differentiator, driven by integration of advanced data analytics and artificial intelligence in monitoring and treatment adaptation.
  • Demand for multi-channel care delivery continues to increase, with online pharmacies and telepharmacy platforms complementing traditional hospital and retail outlets.
  • Collaborative partnerships among pharmaceutical manufacturers, digital health companies, and academic research centers are accelerating clinical validation and expanding service offerings.
  • Segmentation by age, gender, and symptom severity underscores the need for tailored clinical pathways and supports innovation in both product design and service delivery.

Tariff Impact: Navigating Regulatory Change in the Generalized Anxiety Disorder Market

The introduction of United States Tariffs 2025 is reshaping cost and supply dynamics for anxiety treatments, including imported pharmaceutical ingredients and digital health hardware. Organizations are responding by optimizing sourcing, increasing domestic manufacturing, and adopting advanced production techniques. Retailers and distributors are exploring new ingredient sources and agile pricing to maintain patient access. These regulatory headwinds also spur investment in supply chain resilience and accelerate adoption of innovative assembly methods. Ongoing policy developments may offer selective relief but necessitate close monitoring for effective risk mitigation.

Methodology & Data Sources

This report employs a multi-phase research approach combining quantitative market analysis with qualitative stakeholder interviews. Sources include peer-reviewed publications, regulatory filings, market intelligence studies, and global trade documentation. Primary insights were derived from clinicians, supply chain leaders, regulatory professionals, and digital health innovators. Data validation strategies and triangulation were applied to enhance insight robustness.

Why This Report Matters

  • Provides a granular market breakdown to inform investment decisions, expansion strategy, and resource allocation for stakeholders targeting mental health sectors.
  • Enables benchmarking of digital transformation progress, regulatory adaptation, and supply chain resilience relative to industry peers.
  • Guides organization planning to address patient access, cost management, and technology integration in a rapidly changing market context.

Conclusion

The Generalized Anxiety Disorder market landscape is being shaped by digital innovation, evolving regulations, and tailored clinical care. In-depth insights support agile decision-making and future-ready strategy formulation for industry leaders.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Generalized Anxiety Disorder Market, by Treatment Type
8.1. Introduction
8.2. Digital Therapeutics
8.2.1. Mobile Apps
8.2.1.1. Cognitive Behavioral Therapy Apps
8.2.1.2. Mindfulness Apps
8.2.2. Online Platforms
8.2.3. Virtual Reality
8.3. OTC Supplements
8.4. Prescription Drugs
8.4.1. Benzodiazepines
8.4.2. Buspirone
8.4.3. SNRIs
8.4.4. SSRIs
8.5. Therapy Services
8.5.1. Cognitive Behavioral Therapy
8.5.2. Group Therapy
8.5.3. Psychodynamic Therapy
8.5.4. Supportive Counseling
9. Generalized Anxiety Disorder Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.3.1. E-Commerce Portals
9.3.2. Telepharmacy Services
9.4. Retail Pharmacies
10. Generalized Anxiety Disorder Market, by Patient Age Group
10.1. Introduction
10.2. Adolescents
10.3. Adults
10.4. Children
10.5. Elderly
11. Generalized Anxiety Disorder Market, by Gender
11.1. Introduction
11.2. Female
11.3. Male
12. Generalized Anxiety Disorder Market, by Symptom Severity
12.1. Introduction
12.2. Mild
12.3. Moderate
12.4. Severe
13. Americas Generalized Anxiety Disorder Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Generalized Anxiety Disorder Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Generalized Anxiety Disorder Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Pfizer Inc.
16.3.2. Eli Lilly and Company
16.3.3. GlaxoSmithKline plc
16.3.4. AbbVie Inc.
16.3.5. H. Lundbeck a/S
16.3.6. Roche Holding AG
16.3.7. Teva Pharmaceuticals Industries Ltd.
16.3.8. Viatris Inc.
16.3.9. Sandoz International GmbH
16.3.10. Dr. Reddy’s Laboratories Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. GENERALIZED ANXIETY DISORDER MARKET MULTI-CURRENCY
FIGURE 2. GENERALIZED ANXIETY DISORDER MARKET MULTI-LANGUAGE
FIGURE 3. GENERALIZED ANXIETY DISORDER MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC GENERALIZED ANXIETY DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC GENERALIZED ANXIETY DISORDER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. GENERALIZED ANXIETY DISORDER MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. GENERALIZED ANXIETY DISORDER MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. GENERALIZED ANXIETY DISORDER MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY APPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MINDFULNESS APPS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY VIRTUAL REALITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY OTC SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY BENZODIAZEPINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY BUSPIRONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SNRIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SSRIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY COGNITIVE BEHAVIORAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GROUP THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PSYCHODYNAMIC THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SUPPORTIVE COUNSELING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY E-COMMERCE PORTALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TELEPHARMACY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ADOLESCENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ELDERLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MILD, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MODERATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SEVERE, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 69. CANADA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 70. CANADA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 71. CANADA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2030 (USD MILLION)
TABLE 72. CANADA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 73. CANADA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2030 (USD MILLION)
TABLE 74. CANADA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 75. CANADA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 76. CANADA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 77. CANADA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 78. CANADA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2030 (USD MILLION)
TABLE 79. MEXICO GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 80. MEXICO GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 81. MEXICO GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2030 (USD MILLION)
TABLE 82. MEXICO GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 83. MEXICO GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2030 (USD MILLION)
TABLE 84. MEXICO GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 85. MEXICO GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 86. MEXICO GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 87. MEXICO GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 88. MEXICO GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 124. UNITED KINGDOM GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. UNITED KINGDOM GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 128. UNITED KINGDOM GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2030 (USD MILLION)
TABLE 130. GERMANY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 131. GERMANY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 132. GERMANY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2030 (USD MILLION)
TABLE 133. GERMANY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 134. GERMANY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2030 (USD MILLION)
TABLE 135. GERMANY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. GERMANY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 137. GERMANY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 138. GERMANY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 139. GERMANY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2030 (USD MILLION)
TABLE 140. FRANCE GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 141. FRANCE GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 142. FRANCE GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2030 (USD MILLION)
TABLE 143. FRANCE GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 144. FRANCE GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2030 (USD MILLION)
TABLE 145. FRANCE GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. FRANCE GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 147. FRANCE GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 148. FRANCE GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 149. FRANCE GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2030 (USD MILLION)
TABLE 160. ITALY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 161. ITALY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 162. ITALY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2030 (USD MILLION)
TABLE 163. ITALY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 164. ITALY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2030 (USD MILLION)
TABLE 165. ITALY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. ITALY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 167. ITALY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 168. ITALY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 169. ITALY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2030 (USD MILLION)
TABLE 170. SPAIN GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 171. SPAIN GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 172. SPAIN GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2030 (USD MILLION)
TABLE 173. SPAIN GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 174. SPAIN GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2030 (USD MILLION)
TABLE 175. SPAIN GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. SPAIN GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 177. SPAIN GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 178. SPAIN GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 179. SPAIN GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2030 (USD MILLION)
TABLE 190. SAUDI ARABIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 208. SOUTH AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2030 (USD MILLION)
TABLE 210. DENMARK GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 211. DENMARK GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 212. DENMARK GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2030 (USD MILLION)
TABLE 213. DENMARK GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 214. DENMARK GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2030 (USD MILLION)
TABLE 215. DENMARK GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. DENMARK GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 217. DENMARK GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 218. DENMARK GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 219. DENMARK GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2030 (USD MILLION)
TABLE 220. NETHERLANDS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 221. NETHERLANDS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 222. NETHERLANDS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2030 (USD MILLION)
TABLE 223. NETHERLANDS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 224. NETHERLANDS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2030 (USD MILLION)
TABLE 225. NETHERLANDS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 226. NETHERLANDS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 227. NETHERLANDS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 228. NETHERLANDS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2030 (USD MILLION)
TABLE 230. QATAR GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 231. QATAR GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 232. QATAR GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2030 (USD MILLION)
TABLE 233. QATAR GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 234. QATAR GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2030 (USD MILLION)
TABLE 235. QATAR GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. QATAR GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 237. QATAR GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 238. QATAR GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 239. QATAR GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2030 (USD MILLION)
TABLE 240. FINLAND GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 241. FINLAND GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 242. FINLAND GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2030 (USD MILLION)
TABLE 243. FINLAND GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 244. FINLAND GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2030 (USD MILLION)
TABLE 245. FINLAND GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 246. FINLAND GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 247. FINLAND GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 248. FINLAND GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 249. FINLAND GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 258. SWEDEN GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 259. SWEDEN GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2030 (USD MILLION)
TABLE 260. NIGERIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 261. NIGERIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 262. NIGERIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2030 (USD MILLION)
TABLE 263. NIGERIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 264. NIGERIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2030 (USD MILLION)
TABLE 265. NIGERIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 266. NIGERIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 267. NIGERIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 268. NIGERIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 269. NIGERIA GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2030 (USD MILLION)
TABLE 270. EGYPT GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 271. EGYPT GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 272. EGYPT GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2030 (USD MILLION)
TABLE 273. EGYPT GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 274. EGYPT GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2030 (USD MILLION)
TABLE 275. EGYPT GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 276. EGYPT GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 277. EGYPT GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 278. EGYPT GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 279. EGYPT GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2030 (USD MILLION)
TABLE 280. TURKEY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 281. TURKEY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 282. TURKEY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2030 (USD MILLION)
TABLE 283. TURKEY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 284. TURKEY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2030 (USD MILLION)
TABLE 285. TURKEY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 286. TURKEY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 287. TURKEY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 288. TURKEY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 289. TURKEY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2030 (USD MILLION)
TABLE 290. ISRAEL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 291. ISRAEL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 292. ISRAEL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2030 (USD MILLION)
TABLE 293. ISRAEL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 294. ISRAEL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2030 (USD MILLION)
TABLE 295. ISRAEL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 296. ISRAEL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 297. ISRAEL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
TABLE 298. ISRAEL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 299. ISRAEL GENERALIZED ANXIETY DISORDER MARKET SIZE, BY SYMPTOM SEVERITY, 2018-2030 (USD MILLION)
TABLE 300. NORWAY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 301. NORWAY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DIGITAL THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 302. NORWAY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY MOBILE APPS, 2018-2030 (USD MILLION)
TABLE 303. NORWAY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY PRESCRIPTION DRUGS, 2018-2030 (USD MILLION)
TABLE 304. NORWAY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY THERAPY SERVICES, 2018-2030 (USD MILLION)
TABLE 305. NORWAY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 306. NORWAY GENERALIZED ANXIETY DISORDER MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Generalized Anxiety Disorder market report include:
  • Pfizer Inc.
  • Eli Lilly and Company
  • GlaxoSmithKline plc
  • AbbVie Inc.
  • H. Lundbeck A/S
  • Roche Holding AG
  • Teva Pharmaceuticals Industries Ltd.
  • Viatris Inc.
  • Sandoz International GmbH
  • Dr. Reddy’s Laboratories Ltd.

Table Information

Report AttributeDetails
No. of Pages187
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.36 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.09 Billion
Compound Annual Growth Rate5.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Generalized Anxiety Disorder - Pipeline Insight, 2025 - Product Image

Generalized Anxiety Disorder - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From
General Anxiety Disorder (GAD) - Pipeline Insight, 2025 - Product Image

General Anxiety Disorder (GAD) - Pipeline Insight, 2025

  • Clinical Trials
  • 40 Pages
  • Global
From
Generalized Anxiety Disorder Market Report 2025 - Product Image

Generalized Anxiety Disorder Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Anxiety Disorders and Depression Treatment Global Market Report, Forecast by Product, Indication, Country and Company Analysis 2024-2032 - Product Image

Anxiety Disorders and Depression Treatment Global Market Report, Forecast by Product, Indication, Country and Company Analysis 2024-2032

  • Report
  • 180 Pages
  • Global
From
Anxiety Disorders and Depression Treatment Market Size, Share & Trends Analysis Report by Drug Type, Indication (Depression, Anxiety), Distribution Channel, and Region with Growth Forecasts, 2025-2030 - Product Image

Anxiety Disorders and Depression Treatment Market Size, Share & Trends Analysis Report by Drug Type, Indication (Depression, Anxiety), Distribution Channel, and Region with Growth Forecasts, 2025-2030

  • Report
  • 100 Pages
  • Global
From

About the Generalized Anxiety Disorder Market

Generalized Anxiety Disorder (GAD) is a prevalent mental health condition characterized by chronic and excessive worry about multiple events or activities, often disproportionate to the actual likelihood or impact of the perceived threats. The GAD market encompasses a range of treatments and services aimed at managing symptoms and improving quality of life for individuals diagnosed with this disorder. Therapeutic approaches include pharmacotherapy, with medications such as selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) being commonly prescribed. Psychotherapy, particularly cognitive-behavioral therapy (CBT), is also a core component of treatment, offering strategies to modify anxious thought patterns and reduce avoidance behaviors. Additionally, the market includes supportive services such as self-help groups and online resources aimed at educating patients and carers about the disorder. Several pharmaceutical and healthcare companies are active in the GAD market, providing medications, therapies, and services to patients. Some notable players in this market include Pfizer, with products like sertraline (Zoloft), and Eli Lilly, which manufactures duloxetine (Cymbalta). Moreover, GlaxoSmithKline's paroxetine (Paxil) is another therapeutic option for GAD. On the psychotherapeutic front, companies like Talkspace and BetterHelp offer online counseling services, expanding access to mental health care. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.